Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Mr Matthew Parry

Honorary Clinical Research Fellow

United Kingdom

Jump to: Affiliations Publications

Affiliations
Department of Health Services Research and Policy
Faculty of Public Health and Policy

Selected Publications
Impact of comorbidity on patient reported outcome measures for men with localised prostate cancer.
PARRY, MG; Bailey, AV; Belin, TR; Elashoff, D; Foster, C; Graham, I; Kowalski, C; Kwan, L; Millar, J; Sibert, NT; Weller, S; Wilhalme, H; Litwin, MS; Moore, CM; TrueNTH Global Registry,;
2026
BMC urology
Characteristics and outcomes of men presenting with complications of metastatic prostate cancer.
NATHAN, A; PARRY, MG; Cook, A; MAYNE, E; DODKINS, J; Parry, M; VARMA, R; AGGARWAL, A; VAN DER MEULEN, J; Green, JS A; Tree, A; Clarke, N; Cowling, TE;
2026
BJU International
Future Directions of the National Prostate Cancer Audit.
LIU, JK H; Nathan, A; DODKINS, J; Parry, MA; MAYNE, E; Cook, A; Yuen, KY; Chen, A; PARRY, MG; Cowling, TE; Tree, AC; Clarke, NW; VAN DER MEULEN, J;
2026
Clinical oncology (Royal College of Radiologists (Great Britain))
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in England.
DODKINS, J; Cook, A; MAYNE, E; Parry, M; PARRY, MG; Boyle, J; Nossiter, J; COWLING, TE; Tree, A; Clarke, N; VAN DER MEULEN, J; AGGARWAL, A;
2025
European journal of cancer (Oxford, England : 1990)
Is Centralisation of Cancer Services Associated With Under-Treatment of Patients With High-Risk Prostate Cancer?-A National Population-Based Study.
HAN, L; MAYNE, E; DODKINS, J; Sullivan, R; Cook, A; PARRY, M; Nossiter, J; COWLING, TE; Tree, A; Clarke, N; VAN DER MEULEN, J; AGGARWAL, A;
2024
Cancer medicine
Reply to: Letter to the editor regarding the article 'Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound'.
PARRY, MG; Sujenthiran, A; Nossiter, J; Morris, M; Berry, B; NATHAN, A; AGGARWAL, A; Payne, H; VAN DER MEULEN, J; Clarke, NW;
2024
BJU international
Prostate cancer outcomes following whole-gland and focal high-intensity focused ultrasound.
PARRY, MG; Sujenthiran, A; Nossiter, J; MORRIS, M; Berry, B; Nathan, A; AGGARWAL, A; Payne, H; VAN DER MEULEN, J; Clarke, NW;
2023
BJU international
Ethnic diversity in the English urology workforce and BAUS leadership 2009–2020: A longitudinal study
Adasonla, K; Newman, T; Ellis, R; PARRY, M; Shrotri, N; Cresswell, J; Green, JS A;
2023
Journal of Clinical Urology
Treatment-related toxicity using prostate bed versus prostate bed and pelvic lymph node radiation therapy following radical prostatectomy: A national population-based study
Sujenthiran, A; PARRY, MG; Dodkins, J; Nossiter, J; MORRIS, M; Berry, B; Nathan, A; Cathcart, P; Clarke, NW; Payne, H; VAN DER MEULEN, J; AGGARWAL, A;
2023
Clinical and translational radiation oncology
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancer.
Fankhauser, CD; PARRY, MG; Ali, A; COWLING, TE; Nossiter, J; Sujenthiran, A; Berry, B; MORRIS, M; AGGARWAL, A; Payne, H; VAN DER MEULEN, J; Clarke, NW;
2022
European journal of cancer
See more information
Matthew Parry

Contact

United Kingdom